271980 — Jeil Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩179bn
- KR₩229bn
- KR₩705bn
- 27
- 57
- 16
- 22
Annual cashflow statement for Jeil Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 6,965 | -14,986 | -15,009 | 5,201 | -30,143 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 12,765 | 14,760 | 6,980 | 5,897 | 23,613 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -47,769 | 10,194 | -16,004 | -25,846 | -1,554 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -19,046 | 19,100 | -15,147 | -4,981 | 3,213 |
| Capital Expenditures | -2,867 | -5,393 | -16,958 | -9,576 | -6,613 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -2,710 | -2,645 | 4,034 | -2,343 | -684 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -5,577 | -8,037 | -12,924 | -11,919 | -7,297 |
| Financing Cash Flow Items | 38 | 27,498 | 26,001 | — | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 15,133 | 11,069 | 33,618 | 18,766 | 23,063 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -9,622 | 22,070 | 5,483 | 1,545 | 20,485 |